VEGFA and neoplasm: Further studies revealed that VEGF was overexpressed in liver metastasis and had a negative immunoregulatory effect, while the addition of bevacizumab can improve the immunosuppressive microenvironment by blocking VEGFR, thus promoting anti-tumour effects [65, 66].